Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC)

被引:39
|
作者
Ko, Kyungtae [1 ]
Park, Young H. [1 ]
Lee, Jeong W. [1 ]
Ku, Ja H. [1 ]
Kwak, Cheol [1 ]
Kim, Hyeon H. [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea
关键词
nutritional status; renal cell carcinoma; prognosis; body mass index; albumin; cholesterol; BODY-MASS INDEX; PRETREATMENT SERUM-ALBUMIN; FATTY-ACID SYNTHASE; INDEPENDENT PREDICTOR; COLORECTAL-CANCER; PANCREATIC-CANCER; KIDNEY CANCER; WEIGHT-LOSS; SURVIVAL; RISK;
D O I
10.1111/bju.12275
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate the prognosis of patients with renal cell carcinoma (RCC) by nutritional status defined by body mass index (BMI), serum albumin and cholesterol. Patients and Methods This study retrospectively enrolled 1437 patients who underwent radical nephrectomy (932) or partial nephrectomy (505) for RCC. We assigned nutritional status according to the presence of none or one nutritional risk factor (control group) and two or all three of the following nutritional risk factors (nutritional deficiency group). The nutritional factors and thresholds were preoperative albumin level (< 3.5 g/dL), preoperative cholesterol level (< 220 mg/dL), and preoperative BMI (< 23 kg/m(2)) Results The patients' mean (sd) age was 55.23 (12.41) years and BMI was 24.36 (3.17) kg/m(2). The mean (sd) serum cholesterol level was 180.07 (38.24) mg/dL, and the albumin level was 4.2 (0.45) g/dL. In all, 141 (9.8%) patients had none of the nutritional deficiency criteria, 802 (55.8%) had one, 429 (29.9%) had two, and 65 (4.5%) had all three. Clinicopathological variables, i.e. female gender, high tumour stage, positive lymph node metastasis, positive distant metastasis, high nuclear grade and non-clear cell type histopathology were associated with the nutritional deficiency group. In multivariate Cox analysis, nutritional deficiency was an independent predictor for RCC recurrence (hazard ratio [HR] 1.39, 95% confidence interval [CI] 1.05-1.83, P = 0.020) and RCC-related mortality (HR 2.06, 95% CI 1.39-3.03, P < 0.001). Conclusion Nutritional deficiency defined by BMI, serum albumin and cholesterol is an important factor that predicts postoperative prognosis of patients with RCC who have undergone radical or partial nephrectomy.
引用
收藏
页码:775 / 780
页数:6
相关论文
共 50 条
  • [41] Surgical treatment of atypical metastasis from renal cell carcinoma (RCC)
    Antonelli, Alessandro
    Arrighi, Nicola
    Corti, Serena
    Legramanti, Stefano
    Zanotelli, Tiziano
    Cozzoli, Alberto
    Cunico, Sergio Cosciani
    Simeone, Claudio
    BJU INTERNATIONAL, 2012, 110 (11B) : E559 - E563
  • [42] The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis A Meta-Analysis of Cohort Studies
    Chen, Luyao
    Li, Hongzhao
    Gu, Liangyou
    Ma, Xin
    Li, Xintao
    Gao, Yu
    Zhang, Yu
    Shen, Donglai
    Fan, Yang
    Wang, Baojun
    Bao, Xu
    Zhang, Xu
    MEDICINE, 2015, 94 (26)
  • [43] Changing prognosis of renal cell carcinoma: a single-centre experience over 25 years
    Charlesworth, Philip J. S.
    Sullivan, Mark E.
    Protheroe, Andrew
    Turner, Gareth D. H.
    Roberts, Ian S. D.
    Kilbey, Neviana
    Harris, Adrian L.
    Cranston, David
    JOURNAL OF CLINICAL UROLOGY, 2013, 6 (02) : 119 - 124
  • [44] The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma
    Qin, C.
    Cao, Q.
    Ju, X.
    Wang, M.
    Meng, X.
    Zhu, J.
    Yan, F.
    Li, P.
    Ding, Q.
    Chen, J.
    Gu, M.
    Zhang, W.
    Yin, C.
    Zhang, Z.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 981 - 989
  • [45] Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC
    Waldert, Matthias
    Haitel, Andrea
    Marberger, Michael
    Katzenbeisser, Daniela
    Ozsoy, Mehmet
    Stadler, Elisabeth
    Remzi, Mesut
    BJU INTERNATIONAL, 2008, 102 (10) : 1381 - 1384
  • [46] Clinical Characteristics and Prognosis of Renal Cell Carcinoma With Spinal Bone Metastases
    Zhai, Jianpo
    Liu, Ning
    Wang, Hai
    Huang, Guanglin
    Man, Libo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Incidence and long-term prognosis of papillary renal cell carcinoma
    Schrader, A. J.
    Rauer-Bruening, S.
    Olbert, P. J.
    Hegele, A.
    Rustemeier, J.
    Timmesfeld, N.
    Varga, Z.
    Hofmann, R.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (06) : 799 - 805
  • [48] Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival
    Santoni, Matteo
    Monteiro, Fernando Sabino M.
    Massari, Francesco
    Abahssain, Halima
    Aurilio, Gaetano
    Molina-Cerrillo, Javier
    Myint, Zin W.
    Zabalza, Ignacio Ortego
    Battelli, Nicola
    Grande, Enrique
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176
  • [49] The association of hematologic parameters on the prognosis of patients with metastatic renal cell carcinoma
    Dirican, A.
    Kucukzeybek, Y.
    Somali, I.
    Erten, C.
    Demir, L.
    Can, A.
    Payzin, K. Bahriye
    Bayoglu, I. Vedat
    Akyol, M.
    Koseoglu, M.
    Alacacioglu, A.
    Tarhan, M. Oktay
    JOURNAL OF BUON, 2013, 18 (02): : 413 - 419
  • [50] TRIP13 predicts poor prognosis in clear cell renal cell carcinoma
    Kowalewski, Adam
    Jaworski, Damian
    Antosik, Paulina
    Smolinska, Marta
    Ligmanowska, Joanna
    Grzanka, Dariusz
    Szylberg, Lukasz
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (09): : 2909 - 2918